These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 20034141)

  • 1. FDA notifications. Generic efavirenz/emtricitabine/fenofovir has tentative approval.
    AIDS Alert; 2009 Oct; 24(10):119-20. PubMed ID: 20034141
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA notifications. FDA approves generic combination of efavirenz, lamivudine & tenofovir.
    AIDS Alert; 2009 Nov; 24(11):130. PubMed ID: 19960612
    [No Abstract]   [Full Text] [Related]  

  • 3. First of a kind in HIV treatment.
    FDA Consum; 2006; 40(6):34. PubMed ID: 17333565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent FDA approvals and changes.
    AIDS Patient Care STDS; 2010 Feb; 24(2):133-4. PubMed ID: 20156092
    [No Abstract]   [Full Text] [Related]  

  • 5. [Efavirenz in fixed combination with tenofovir and emtricitabine. Long-term effectiveness verified in new studies].
    Wepner U
    MMW Fortschr Med; 2011 May; 153(18):20-1. PubMed ID: 21604586
    [No Abstract]   [Full Text] [Related]  

  • 6. Efavirenz + emtricitabine + tenofovir: new combination. HIV infection: do not modify ongoing therapy just to use one less tablet. Better adherence than with separate dosing has not been demonstrated, while reduced efficacy is plausible.
    Prescrire Int; 2009 Jun; 18(101):105. PubMed ID: 19637416
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA grants tentative approval to first generic version of antiretroviral Viread.
    AIDS Patient Care STDS; 2008 Jan; 22(1):86. PubMed ID: 18453039
    [No Abstract]   [Full Text] [Related]  

  • 8. Generic Truvada approved.
    AIDS Patient Care STDS; 2009 May; 23(5):395. PubMed ID: 19422066
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA notifications. FDA grants tentative approval of efavirenz.
    AIDS Alert; 2007 Sep; 22(9):104. PubMed ID: 18411463
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA notifications. Generic emtricitabine is approved by the FDA.
    AIDS Alert; 2009 Feb; 24(2):21. PubMed ID: 19222147
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA approves new 4-drug once-a-day HIV treatment.
    AIDS Policy Law; 2012 Oct; 27(11):1. PubMed ID: 23155506
    [No Abstract]   [Full Text] [Related]  

  • 12. [Budget impact of a set-dose combination of efavirenz-emtricitabine-tenofovir in the treatment of patients infected with HIV-1].
    Oyagüez I; Casado MA; Cotarelo M; Ramírez-Arellano A; Mallolas J
    Farm Hosp; 2009; 33(5):247-56. PubMed ID: 19775575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of tenofovir/emtricitabine or abacavir/lamivudine in combination with efavirenz in treatment naïve HIV patients: a 5 year retrospective observational cohort study. (the TOKEN Study).
    Pammi M; Arumainayagam J; Kumari B; Ahmed-Jushuf I; Carlin EM; Chandramani S; Riddell L; Ghanem M; Das S
    Int J Clin Pract; 2013 Sep; 67(9):922-3. PubMed ID: 23952469
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA notifications. Complera approved.
    AIDS Alert; 2011 Nov; 26(11):130-1. PubMed ID: 22164521
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA notifications. FDA's tentative approval for generic Tenofovir.
    AIDS Alert; 2008 Jan; 23(1):11-2. PubMed ID: 18572475
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA makes final approvals.
    AIDS Patient Care STDS; 2006 May; 20(5):381. PubMed ID: 16758553
    [No Abstract]   [Full Text] [Related]  

  • 17. Effectiveness and safety of generic fixed-dose combination of tenofovir/emtricitabine/efavirenz in HIV-1-infected patients in Western India.
    Pujari S; Dravid A; Gupte N; Joshi K; Bele V
    Medscape J Med; 2008; 10(8):196. PubMed ID: 18924648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDA notifications. Generic efavirenz capsules tentatively approved by FDA.
    AIDS Alert; 2009 Dec; 24(12):143. PubMed ID: 20063479
    [No Abstract]   [Full Text] [Related]  

  • 19. European Commission approves Atripla.
    AIDS Patient Care STDS; 2008 Jan; 22(1):87-8. PubMed ID: 18453042
    [No Abstract]   [Full Text] [Related]  

  • 20. No changes in efavirenz plasma concentrations in HIV-infected patients who switch from Stocrin to Atripla.
    Burger D; van Luin M; Bosch M; van der Ven A; Brouwer AM; Keuter M; Dofferhoff T; Koopmans PP
    J Acquir Immune Defic Syndr; 2010 Aug; 54(5):e12-3. PubMed ID: 20647821
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.